298. Hereditary pancreatitis Clinical trials / Disease details
Clinical trials : 95 / Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05771675 (ClinicalTrials.gov) | June 2023 | 2/2/2023 | Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis | Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis | Recurrent Acute Pancreatitis;Chronic Pancreatitis | Drug: Simvastatin;Drug: Placebo | Cedars-Sinai Medical Center | United States Department of Defense | Not yet recruiting | 18 Years | 75 Years | All | 90 | Early Phase 1 | NULL |